Re: Ultra-Short Duration Direct Acting Antiviral Prophylaxis to Prevent Virus Transmission from Hepatitis C Viremic Donors to Hepatitis C Negative Kidney Transplant Recipients

被引：0
|
作者：
Goldfarb, David A.
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 204卷 / 04期
关键词：
D O I：
10.1097/JU.0000000000001214
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：868 / 868
页数：1
相关论文
共 50 条
  • [21] Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients
    Axelrod, David A.
    Lentine, Krista L.
    Balakrishnan, Ramji
    Chang, Su-Hsin
    Alhamad, Terek
    Xiao, Huiling
    Kasiske, Bertran L.
    Bloom, Roy D.
    Schnitzler, Mark A.
    TRANSPLANTATION DIRECT, 2020, 6 (12): : E627
  • [22] Multivisceral transplantation utilizing hepatitis C virus-viremic donors for hepatitis C virus-negative recipients
    Addison, Vanessa
    Goldberg, David Seth
    Vianna, Rodrigo
    Martin, Eric
    Garcia, Jenn
    AMERICAN JOURNAL OF TRANSPLANTATION, 2025, 25 (01) : 204 - 208
  • [23] Alemtuzumab vs Antithymocyte Globulin Induction in Hepatitis C Viremic Donors to Hepatis C Negative Kidney Transplant Recipients
    Walter, K.
    Mincemoyer, L.
    Giang, J.
    Suero, J.
    Shah, N.
    Szempruch, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 689 - 690
  • [24] Efficacy and Tolerability of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in Kidney Transplant Recipients
    Suna, Nuretdin
    Etik, Digdem Ozer
    Ocal, Serkan
    Selcuk, Haldun
    Dagli, Ulku
    Hilmioglu, Fatih
    Boyacioglu, Sedat
    Haberal, Mehmet
    TRANSPLANTATION, 2018, 102 : S909 - S909
  • [25] REHANNA: Renal Transplants in Hepatitis C Negative Recipients with Nucleic Acid Positive Donors with Short Course Direct Acting Antiviral Prophylaxis.
    Durand, C.
    Barnaba, B.
    Brown, D.
    Bair, N.
    Naqvi, F.
    Bowring, M.
    Segev, D.
    Sulkowski, M.
    Desai, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1121 - 1121
  • [26] Safety of Direct Acting Antiviral Therapy in Kidney Transplant Recipients with Chronic Hepatitis C Infection
    El-Halawany, Hani
    Qureshi, Kamran
    GASTROENTEROLOGY, 2016, 150 (04) : S1105 - S1106
  • [27] Ultra-Short Duration Prophylaxis for Hepatitis C Donor Positive to Recipient Negative Simultaneous Kidney/Pancreas Transplants.
    Gupta, G.
    Yakubu, I.
    Khan, A.
    Sterling, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 850 - 851
  • [28] Hepatocellular carcinoma after direct-acting antiviral therapy in kidney transplant recipients infected with hepatitis C virus
    Calca, Rita
    Jorge, Cristina
    Lebre, Luis
    Cacheira, Eunice
    Querido, Sara
    Nascimento, Celia
    Adragao, Teresa
    Bruges, Margarida
    Weigert, Andre
    Machado, Domingos
    NEFROLOGIA, 2020, 40 (06): : 675 - 676
  • [29] Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A Small Uncontrolled Trial
    Desai, Niraj M.
    Leung, Sherry G.
    Motter, Jennifer D.
    Segev, Dorry L.
    Warren, Daniel
    Durand, Christine M.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (12) : 1682 - 1684
  • [30] Detection of Hepatitis C Antibodies Without Viral Transmission in Hepatitis C-Negative Recipients Receiving Kidneys From Hepatitis C-Positive Donors Treated With Direct-Acting Antiviral Therapy
    Agarwal, Neeru
    Davis, Rebecca J.
    Gracey, David M.
    Wong, Germaine
    Kable, Kathy
    Wong, Jeffrey K. W.
    Nankivell, Brian J.
    Strasser, Simone
    Wyburn, Kate
    TRANSPLANTATION, 2018, 102 (03) : e121 - e122
12345